These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15586893)

  • 21. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil.
    Souza MT; Pinho TL; Santos MD; Santos Ad; Monteiro VL; Fonsêca LM; Ferreira PA; Ferreira Ade S
    Braz J Infect Dis; 2012; 16(6):517-20. PubMed ID: 23168305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of hepatitis B virus infection and seroconvertion to anti-HBsAg in laboratory staff in Goiânia, Goiás.
    Silva PA; Fiaccadori FS; Borges AM; Silva SA; Daher RR; Martins RM; Cardoso Dd
    Rev Soc Bras Med Trop; 2005; 38(2):153-6. PubMed ID: 15821790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-Sectional Study to Determine the Prevalence of Hepatitis B and C Virus Infection in High Risk Groups in the Northeast Region of Brazil.
    Ribeiro Barbosa J; Sousa Bezerra C; Carvalho-Costa FA; Pimentel de Azevedo C; Lopes Flores G; Baima Colares JK; Malta Lima D; Lampe E; Melo Villar L
    Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28714924
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus.
    Hoyos-Orrego A; Massaro-Ceballos M; Ospina-Ospina M; Gómez-Builes C; Vanegas-Arroyave N; Tobón-Pereira J; Jaramillo-Hurtado J; Rugeles-López MT
    Rev Inst Med Trop Sao Paulo; 2006; 48(6):321-6. PubMed ID: 17221128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of Hepatitis B virus infection among an Afro-descendant community in Brazil.
    Motta-Castro AR; Yoshida CF; Lemos ER; Oliveira JM; Cunha RV; Lewis-Ximenez LL; Cabello PH; Lima KM; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jan; 98(1):13-7. PubMed ID: 12700856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand.
    Apidechkul T
    BMC Infect Dis; 2019 Feb; 19(1):125. PubMed ID: 30727952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L; Adegoke AO; Aboderin AO; Huraina HA
    West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
    Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A
    Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus infection in a population exposed to occupational hazards: firefighters of a metropolitan region in central Brazil.
    Contrera-Moreno L; de Andrade SM; Pontes ER; Stief AC; Pompilio MA; Motta-Castro AR
    Rev Soc Bras Med Trop; 2012; 45(4):463-7. PubMed ID: 22930044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America.
    Scott-Wright A; Hakre S; Bryan JP; Jaramillo R; Reyes LG; Cruess D; Macarthy PO; Gaydos JC
    Am J Trop Med Hyg; 1997 Mar; 56(3):285-90. PubMed ID: 9129530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
    Ningyu Z; Ying Z; Hui L
    J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B and C in a Brazilian deaf community.
    Pacher BM; Costa MR; Nascimento MM; Moura MC; Passos AD
    Rev Soc Bras Med Trop; 2015; 48(5):603-6. PubMed ID: 26516972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.